Risk of chronic kidney disease in hypertensive patients with other metabolic conditions

Journal of Human Hypertension

Volumn 22, Issue 2, 2008, Pages 132-134

  Weycker, D ^a   Nichols, G A ^b   O'Keeffe Rosetti, M ^b   Edelsberg, J ^a   Vincze, G ^c   Khan, Z M ^c   Oster, G ^a  

^a POLICY ANALYSIS INC PAI   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC DISORDER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING;

BODY MASS INDEX; CHRONIC DISEASE; DIABETES COMPLICATIONS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; KIDNEY DISEASES; MALE; METABOLIC DISEASES; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 38349189803     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002276     Document Type: Article

References (11)

1. National Kidney Foundation DOQI Guidelines. K/DOQI Clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification, Available at http://www.kidney.org/professionals/ kdoqi/guidelines.cfm. Accessed November 5, 2005.
2. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140.
3. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PWF, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850.
4. Sowers JR. Treatment of hypertension in patients with diabetes. Arch Intern Med 2004; 164: 1850-1857.
5. Kannel WB. Risk stratification in hypertension: New insights from the Framingham Study. Am J Hypertens 2000; 13: 3S-10S.
6. Verhave JC, Hillege HL, Burgerhof JGM, Gansevoort RT, De Zeeuw D, De Jong PE. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 2005; 67: 1967-1973.
7. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999; 159: 1873-1880.
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130 461-470.
9. Weycker D, Nichols GA, O'Keeffe-Rosetti M, Edelsberg J, Khan ZM, Kaura S et al. Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens 2007; 20: 599-607.
10. American Diabetes Association. Standards of Medical Care-2007. Diabetes Care 2007; 30: S4-S41.
11. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483.